Literature DB >> 1607330

The incidence of antibiotic resistance in aerobic faecal flora in south India.

S G Amyes1, S Tait, C J Thomson, D J Payne, L S Nandivada, M V Jesudason, U D Mukundan, H K Young.   

Abstract

During a field study in South India in 1989, faecal specimens were collected from residents in villages and the town of Vellore in South India. Examination of the faecal specimens revealed that virtually the whole population carried commensal bacteria resistant to trimethoprim, ampicillin and chloramphenicol. Most specimens contained more than one type of bacterium resistant to each antibiotic. There was less resistance to nalidixic acid, with a higher proportion in the town (33%) than in the villages (13%). Although there was little cross-resistance of the ampicillin-resistant strains to later generation cephalosporins, 50% were resistant to the combination of amoxycillin and clavulanic acid. There was no significant cross-resistance of the nalidixic acid-resistant strains to fluorinated 4-quinolones, despite the free availability of ciprofloxacin and norfloxacin in the area. The probable reason for the high incidence of resistance to first generation antimicrobials is the extensive use of these agents, coupled with continuous exposure to large numbers of faecal micro-organisms.

Entities:  

Mesh:

Year:  1992        PMID: 1607330     DOI: 10.1093/jac/29.4.415

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  13 in total

1.  Problem of antimicrobial resistance of fecal aerobic gram-negative bacilli in the elderly.

Authors:  T Leistevuo; P Toivonen; M Osterblad; M Kuistila; A Kahra; A Lehtonen; P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

2.  Beta-lactam resistance in normal faecal flora from South Africa.

Authors:  P M Shanahan; C J Thomson; S G Amyes
Journal:  Epidemiol Infect       Date:  1995-10       Impact factor: 2.451

3.  The prevalence of antimicrobial resistance in human faecal flora in South Africa.

Authors:  P M Shanahan; B A Wylie; P V Adrian; H J Koornhof; C J Thomson; S G Amyes
Journal:  Epidemiol Infect       Date:  1993-10       Impact factor: 2.451

4.  Screening for antimicrobial resistance in fecal samples by the replica plating method.

Authors:  M Osterblad; T Leistevuo; P Huovinen
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

5.  Antimicrobial and mercury resistance in aerobic gram-negative bacilli in fecal flora among persons with and without dental amalgam fillings.

Authors:  M Osterblad; J Leistevuo; T Leistevuo; H Järvinen; L Pyy; J Tenovuo; P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

6.  The prevalence and genetics of resistance to commonly used antimicrobial agents in faecal Enterobacteriaceae from children in Bangladesh.

Authors:  K Z Mamun; P Shears; C A Hart
Journal:  Epidemiol Infect       Date:  1993-06       Impact factor: 2.451

7.  Beta-lactam resistance in aerobic faecal flora from general practice patients in the UK.

Authors:  P M Shanahan; C J Thomson; S G Amyes
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-09       Impact factor: 3.267

8.  Trimethoprim resistance in South African isolates of aerobic gram-negative faecal flora.

Authors:  P V Adrian; H J Koornhof; B A Wylie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-12       Impact factor: 3.267

9.  The prevalence of antibiotic-resistant faecal Escherichia coli in healthy volunteers in Venezuela.

Authors:  H J van de Mortel; E J Jansen; G J Dinant; N London; E Palacios Prü; E E Stobberingh
Journal:  Infection       Date:  1998 Sep-Oct       Impact factor: 3.553

10.  Comparison of the selection of antimicrobial resistance in fecal Escherichia coli during enrofloxacin administration with a local drug delivery system or with intramuscular injections in a swine model.

Authors:  Romain Béraud; Louis Huneault; Dave Bernier; Francis Beaudry; Ann Letellier; Jérôme R E del Castillo
Journal:  Can J Vet Res       Date:  2008-07       Impact factor: 1.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.